首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1357952

人类微生物组市场：按产品类型、用途、适应症、配销通路和地区

Human Microbiome Market, By Product Type, Application, Disease Indication (Auto Immune Disorder, Clostridium Difficile Infection, Metabolic Disorder, Inflammatory Bowel disorder, Infectious Diseases, & Others), Distribution Channel, & Geography

出版日期: 2023年09月11日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2023 年，全球人类微生物组市场价值 6.179 亿美元，预计在预测期内（2023-2030 年）年复合成长率为 24.6%。

报告范围		报告详情
基准年	2022年	2023年市场规模	6.179 亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期年复合成长率	24.60%	2030年市场规模预测	28.845 亿美元

人类微生物全球市场占有率(%)（依产品类型），2023 年

人类微生物组是指存在于人类体内和体外的所有微生物，是构成人类宏基因组的微生物基因组的集合。人类微生物群由 10 兆至 100 兆个共生微生物细胞结构，主要是人类肠道细菌。年龄、营养状况、生活方式、荷尔蒙变化、遗传基因和潜在疾病是人体微生物群的主要要素，微生物群的变化或失衡可能导致癌症、肠道炎症，甚至可能导致危及生命的疾病，包括心血管疾病由于抗生素抗药性而导致的疾病和难以治疗的细菌感染疾病。微生物组的作用是促进食物消化、调节免疫系统并产生维生素 K、维生素 B 和维生素 B12 等维生素。根据2022 年8 月发表在《微生物技术杂誌》上的一篇论文，组织免疫反应由微生物组组成控制，每个组织都有独特的微环境，使其微生物组组成不同。具有不同的微生物组组成，特别是与不同类型的癌症有关，如乳腺癌、结肠癌、肾癌、肺癌和皮肤癌。因此，微生物组产业的主要企业都在关注研究。

市场动态

微生物组产业的主要参与者正在专注于宏基因组学和转录组学等新分子技术的研发。营养不良研究和感染疾病的最新进展确立了基于微生物组的策略的潜力，可以解决全球健康中一些最大的挑战，包括癌症、慢性胃肠道发炎、心血管疾病、焦虑和忧郁。例如，2023年4月，开发微生物组治疗药物的Ceres Therapeutics公司宣布开发一款给药VOWSTT的药物，旨在预防成人在对复发性CDI进行抗生素治疗后復发艰难梭菌感染疾病。微生物组疗法已获得美国食品药物管理局(FDA) 的核准。因此，人类微生物组领域的持续研究和开发为製药公司开发涉及治疗各种罕见疾病的创新药物和治疗方法提供了机会。

本研究的主要特点

本报告详细分析了全球人类微生物组市场，并提供了以2022年为基准年的预测期（2023-2030年）的市场规模和年复合成长率(CAGR)。它揭示了不同细分市场的潜在收入机会，并解释了市场有吸引力的投资提案矩阵。
它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
该报告根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球人类微生物组市场的主要企业。
该报告的见解将使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
全球人类微生物组市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球人类微生物组市场的各种策略矩阵来促进他们的决策。

公司简介
- Seres Therapeutics
- BIOMESENSE
- Microbiotica
- Vedanta Biosciences, Inc.
- SECOND GENOME THERAPEUTICS
- Finch Therapeutics Group, Inc
- Enterome
- BiomX
- MaaT Pharma
- Azitra
- Illumina, Inc
- Locus Biosciences, Inc
- Finch Therapeutics Group, Inc
- Rebiotix Inc
- Servatus Ltd
- Microbiome Research Pvt. Ltd
- AOBiome
- Axial Therapeutics, Inc
- Biomica.

第11章章节

参考
调查方法

简介目录

Product Code: CMI182

Global human microbiome market is estimated to be valued at US$ 617.9 Mn in 2023, and is expected to exhibit a CAGR of 24.6% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 617.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	24.60%	2030 Value Projection:	US$ 2,884.5 Mn

Global Human Microbiome Market Share (%), By Product Type, 2023

Human microbiome are the full range of microorganisms that are present inside and outside the Humans, It is collection of microbial genomes that contribute to metagenome, of a human. The human micro biota consists of the 10-100 trillion symbiotic microbial cells primarily bacteria in the gut the human. The age, nutrition, lifestyle, hormonal changes, inherited genes, and underlying disease are major determinants of the human microbiome, and any change or in balance in microbiota can cause life threatening illness such as cancer, bowel inflammatory disease, cardiovascular disease, and difficult-to-treat bacterial infections due to antibiotic resistance. Their roles ranges from enabling easy digestion of food, regulation of immune system, and production of vitamins such as Vitamin K, Vitamin B, and Vitamin B12. According to the article published published by journal of microbial biotechnology, published on August 2022, tissue immune responses are regulated by their microbiome composition, and each tissue has their specific microenvironment that makes their microbiome composition different, particularly in the context of different types of cancer, such as breast, colorectal, kidney, lung, and skin. Herein, key players in the microbiome industry are focusing on researches and studies.

Market Dynamics

The key players in the microbiome industry are focusing on researches and development of new molecular technologies such as metagenomics, transcriptomics. Recent advances in malnutrition research and infectious disease have established the potential for microbiome-based strategies to address the biggest challenges in global health including cancer, chronic inflammation in GIT, CVD, anxiety and depression, and others. For instance, in April 2023, Seres Therapeutics, a microbiome therapeutics company that developsbiological drugs, received the U.S. food and Drug Administration approval for it's first orally administered microbiome therapeutic drug named 'VOWSTT' for prevention of recurrence of C. difficile infection in adults following antibacterial treatment for recurrent CDI. Thus, the ongoing research and development in the field of human microbiome offer opportunities for the pharmaceutical companies to develop more innovative drugs or therapies that are involved to treat various range of rare diseases.

Key features of the study:

This report provides an in-depth analysis of the global human microbiomes market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global human microbiomes market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Seres Therapeutics, BIOMESENSE, Microbiotica, Vedanta Biosciences, Inc., SECOND Seres Therapeutics, Biomesense, Microbiotica, Infant Bacterial Therapeutics AB, Vedanta Biosciences, Inc., Second genome therapeutics, 4D Pharma Ferring Inc, Enterome, BiomX, MaaT Pharma, Azitra, Illumina, Inc, Locus Biosciences, Inc, Finch Therapeutics Group, Inc, Rebiotix Inc, Servatus Ltd, Microbiome Research Pvt. Ltd, AOBiome, Axial Therapeutics, Inc, Biomica
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global human microbiomes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human microbiomes market

Detailed Segmentation:

Global Human Microbiomes Market, By Product Type:
- Food
- Probiotics
- Prebiotics
- Medical Food Supplements
- Microbiome Drugs
- Fecal Microbiota Transplant
- Others (Symbiotic, Antibiotics, etc.)
Global Human Microbiome Market, By Application:
- Therapeutics
- Diagnostics
- Nutrition and Deities
- Others (Cosmetics, Animal health etc. )
Global Human Microbiome Market, By Disease Indication:
- Auto Immune Disorder
- Clostridium Difficile Infection
- Metabolic Disorder
- Inflammatory Bowel disorder
- Infectious Diseases
- Others (Cancer, Rare Diseases)
Global Human Microbiome Market, By Disribution Channel:
- Hospital
- Retail Pharmacies
- Online Pharmacies
Global Human Microbiome Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Seres Therapeutics
- Biomesense
- Microbiotica
- Infant Bacterial Therapeutics AB
- Vedanta Biosciences, Inc.
- SECOND GENOME THERAPEUTICS
- Finch Therapeutics Group, Inc
- Enterome
- BiomX
- MaaT Pharma
- Azitra
- Illumina, Inc
- Locus Biosciences, Inc
- Finch Therapeutics Group, Inc
- Rebiotix Inc
- Servatus Ltd
- Microbiome Research Pvt. Ltd
- AOBiome
- Axial Therapeutics, Inc
- Biomica

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Disease Indication
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Human Microbiome Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Human Microbiome Market, By Product Type, 2018- 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Food
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Probiotics
- Prebiotics
- Medical Food Supplements
Microbiome Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Fecal Microbiota Transplant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others (Symbiotic, Antibiotics, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Human Microbiome Market, By Application, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Nutrition and Deities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

7. Global Human Microbiome Market, By Disease Indication, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Auto Immune Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Clostridium Difficile Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Metabolic Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Inflammatory Bowel Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others (Cancer, Rare Diseases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

8. Global Human Microbiome Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

9. Global Human Microbiome Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- U.S.
- Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa

10. Competitive Landscape

Company Profiles
- Seres Therapeutics
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- BIOMESENSE
- Microbiotica
- Vedanta Biosciences, Inc.
- SECOND GENOME THERAPEUTICS
- Finch Therapeutics Group, Inc
- Enterome
- BiomX
- MaaT Pharma
- Azitra
- Illumina, Inc
- Locus Biosciences, Inc
- Finch Therapeutics Group, Inc
- Rebiotix Inc
- Servatus Ltd
- Microbiome Research Pvt. Ltd
- AOBiome
- Axial Therapeutics, Inc
- Biomica.